Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

FUJIFILM Healthcare Americas Corporation recalls ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breas

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Devices had an unapproved slabbing software function enabled for use.
Products
  • ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breas
Where it was sold

Worldwide distribution - US Nationwide and the countries of Canada, Chile, Ecuador.

Nationwide

Units affected
293 units
About this recall
ASPRIRE Cristalle Mammography System (cleared under K212873) installed with the ASPIRE Cristalle Digital Breast Tomosynthesis (DBT) Option (approved under P160031).